BridgeBio Pharma Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2017 | — | $-43.9M | $-43.8M |
| FY2018 | — | $-183.7M | $-169.5M |
| FY2019 | $40.6M | $-266.2M | $-288.6M |
| FY2020 | $8.2M | $-474.5M | $-505.5M |
| FY2021 | $69.7M | $-576.6M | $-586.5M |
| FY2022 | $77.6M | $-512.2M | $-484.7M |
| FY2023 | $9.3M | $-607.4M | $-653.3M |
| FY2024 | $221.9M | $-593.0M | $-543.3M |
| FY2025 | $502.1M | $-523.4M | $-732.9M |
A great business at a fair price is superior to a fair business at a great price.